丽珠医药(01513)9月10日斥资420.41万元回购10.52万股A股

Core Viewpoint - The company, Lijun Pharmaceutical (01513), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will spend 4.2041 million yuan to repurchase 105,200 A-shares [1] - The buyback is scheduled for September 10, 2025, suggesting a strategic long-term investment approach [1]